search
Back to results

Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain

Primary Purpose

Chronic Low-back Pain

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindfulness-based dance/movement therapy (M-DMT)
Chronic pain social support group
Sponsored by
Drexel University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Low-back Pain focused on measuring Dance/movement therapy, Mindfulness-based dance/movement therapy, Chronic pain management, Creative Arts Therapies, Non-pharmacological intervention, Online intervention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  • age > 18 years
  • current non-specific cLBP that has persisted at least 3 months, and has resulted in pain on at least half the day in the past 6 months
  • proficient in English
  • average pain severity and interference ratings >3/10 on a 0-10 numeric rating scale
  • if taking pain medication(s), dosage must be stabilized for a minimum of 3 months
  • patients agree not to seek additional therapies for the duration of this study beyond those already included in their current treatment regimen or new treatments prescribed by their physician
  • naïve to DMT.
  • those who have adequate computer literacy (e.g., know how to use a computer to perform basic tasks such as open/send emails, use internet, fill-out online surveys) and access to the virtual delivery format (i.e., internet service and a personal computer device such as laptop, desktop, tablet PC).

Exclusion Criteria:

  • pregnancy
  • severe and/or progressive medical, neurological, substance dependence within the last 6 months or severe mental illness (i.e., psychosis, mania) that would prevent active participation
  • cognitive impairment that prohibits informed consent
  • back surgery in the last 6 months
  • low back pain attributable to a recognizable, known specific pathology (e.g. infection, tumor, osteoporosis, fracture, structural deformity, inflammatory disorder, radicular syndrome, or cauda equina syndrome
  • wheelchair-bound or unable to move without assistance
  • involvement in impending litigation or judgment for disability or worker's compensation.

Sites / Locations

  • Drexel UniversitsyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Mindfulness-based dance/movement therapy

Chronic pain social support group

Arm Description

Participants assigned to the M-DMT group condition will receive care as usual plus 12 weekly 90-minute group M-DMT sessions delivered online by a board-certified dance/movement therapist. The therapist is instructed to follow the M-DMT manualized protocol.

Participants assigned to the control condition will participate in a 12-session (90-minute session/week) online social support group.

Outcomes

Primary Outcome Measures

Feasibility of Recruitment: Number of participants eligible
Number of participants eligible for randomization to the study intervention
Recruitment Rate
Proportion of participants randomized relative to total trial referrals
Recruitment time
Number of participate enrolled per month
Feasibility of recruiting male participants: Proportion of male participant enrolled
Proportion of male participant enrolled to the study
Treatment Completion Rate
We expect 80% of participants to complete at least 9/12 M-DMT sessions
Retention Rate
Proportion of participants who complete follow-up questionnaires
Reason for withdrawal
Assessed by an open-ended question, "What was the reason for discontinuing your participation?" administered by a study staff during a phone interview
M-DMT intervention credibility and expectancy
Credibility/Expectancy Questionnaire (range 3-27; higher scores reflect greater treatment expectancy and rationale credibility)
Treatment Fidelity
Treatment fidelity assessment form developed by the researcher (range: varies between sessions depending on the number of items included in the particular session; A total score of 80% and higher reflects adequate treatment fidelity)
Treatment satisfaction and acceptability: Likert-scale survey
via Likert-scale surveys; on scale of 1 to 5, 1 being not satisfied; 5 being very satisfied (i.e higher number, better outcome).
M-DMT intervention acceptability
Exit interview based on an interview protocol developed by the researcher
Adverse Event
Number of adverse events

Secondary Outcome Measures

Pain intensity: PROMIS® Pain Intensity-Short Form (SF)3a
PROMIS® Pain Intensity-Short Form (SF)3a (A 5-point (from 1= Had no pain to 5= Very Severe) rating scale is used in each of the 3 items; higher results mean higher intensity of pain.
Pain interference: PROMIS® Pain Interference -8a
PROMIS® Pain Interference -8a (A 5-point (from 1= Not at all to 5= Very much) rating scale is used on each of the 8 items; higher scores reflect greater pain interference
Chronic pain acceptance: Chronic Pain Acceptance Questionnaire
Chronic Pain Acceptance Questionnaire (A seven-point (from 0= Never to 6 = Always) rating scale is used in each of the 20 items; higher results mean high pain acceptance)
Mindfulness
Cognitive and Affective Mindfulness Scale (A 4-point (Rarely/not at all to almost always) rating scale is used in each of the 12 items; higher values reflect higher mindful qualities
Physical activity (Accelerometry data)
An accelerometer, ActiGraph GT9X will be used to measure the change in participants physical activity between baseline and 2 endpoints (12 and 24 weeks)
Physical activity (Self-report data)
Self-report assessment of physical activity will be done through UCLA Activity Scale (One item out of 10 will be checked to best describe current activity level)

Full Information

First Posted
May 29, 2019
Last Updated
April 13, 2021
Sponsor
Drexel University
Collaborators
National Center for Complementary and Integrative Health (NCCIH), Stony Brook University
search

1. Study Identification

Unique Protocol Identification Number
NCT03986489
Brief Title
Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain
Official Title
Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Unknown status
Study Start Date
April 1, 2019 (Actual)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
July 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Drexel University
Collaborators
National Center for Complementary and Integrative Health (NCCIH), Stony Brook University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate the feasibility, acceptability and credibility of a mindfulness-based dance/movement therapy (M-DMT) protocol that is delivered online; to assess and improve methodological procedures for conducting a randomized controlled trial (RCT) test of M-DMT; and to demonstrate proof of principle by gathering information about the process of change between M-DMT and a control condition. This is the first study to address the potential of M-DMT as a creative, non-opioid intervention for chronic back pain. Therefore, the findings of this study will provide important methodological and protocol data and substantive pilot data necessary for the next phase of this line of research, namely a fully powered RCT to evaluate efficacy and treatment mechanisms of action. Data obtained as part of this study will be instrumental for informing the systematic evaluation of M-DMT for chronic back pain care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Low-back Pain
Keywords
Dance/movement therapy, Mindfulness-based dance/movement therapy, Chronic pain management, Creative Arts Therapies, Non-pharmacological intervention, Online intervention

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
64 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mindfulness-based dance/movement therapy
Arm Type
Experimental
Arm Description
Participants assigned to the M-DMT group condition will receive care as usual plus 12 weekly 90-minute group M-DMT sessions delivered online by a board-certified dance/movement therapist. The therapist is instructed to follow the M-DMT manualized protocol.
Arm Title
Chronic pain social support group
Arm Type
Active Comparator
Arm Description
Participants assigned to the control condition will participate in a 12-session (90-minute session/week) online social support group.
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness-based dance/movement therapy (M-DMT)
Other Intervention Name(s)
Dance/Movement Therapy
Intervention Description
M-DMT includes benefits of physical activity, group psychotherapy, mindfulness training, and an art-based intervention in a unified practice. Each online session focuses on different psycho-educational topics about chronic low back pain management and links these topics with specific M-DMT activities that incorporate mindfulness-based principles and techniques.
Intervention Type
Behavioral
Intervention Name(s)
Chronic pain social support group
Intervention Description
The therapist will facilitate online open group discussions about participants' experiences with or reactions to the topic of discussion and will promote empathy among group members. The therapist will use client-centered, reflective listening techniques but will not prescribe any specific recommendations for change. Each week, SSG participants will receive emails with brief information about the topic discussed during the group session.
Primary Outcome Measure Information:
Title
Feasibility of Recruitment: Number of participants eligible
Description
Number of participants eligible for randomization to the study intervention
Time Frame
Baseline
Title
Recruitment Rate
Description
Proportion of participants randomized relative to total trial referrals
Time Frame
Baseline
Title
Recruitment time
Description
Number of participate enrolled per month
Time Frame
Baseline
Title
Feasibility of recruiting male participants: Proportion of male participant enrolled
Description
Proportion of male participant enrolled to the study
Time Frame
Baseline
Title
Treatment Completion Rate
Description
We expect 80% of participants to complete at least 9/12 M-DMT sessions
Time Frame
12 weeks following receipt of treatment
Title
Retention Rate
Description
Proportion of participants who complete follow-up questionnaires
Time Frame
24 weeks
Title
Reason for withdrawal
Description
Assessed by an open-ended question, "What was the reason for discontinuing your participation?" administered by a study staff during a phone interview
Time Frame
12 weeks following receipt of treatment
Title
M-DMT intervention credibility and expectancy
Description
Credibility/Expectancy Questionnaire (range 3-27; higher scores reflect greater treatment expectancy and rationale credibility)
Time Frame
1 week
Title
Treatment Fidelity
Description
Treatment fidelity assessment form developed by the researcher (range: varies between sessions depending on the number of items included in the particular session; A total score of 80% and higher reflects adequate treatment fidelity)
Time Frame
1-12 weeks
Title
Treatment satisfaction and acceptability: Likert-scale survey
Description
via Likert-scale surveys; on scale of 1 to 5, 1 being not satisfied; 5 being very satisfied (i.e higher number, better outcome).
Time Frame
12 weeks post-randomization
Title
M-DMT intervention acceptability
Description
Exit interview based on an interview protocol developed by the researcher
Time Frame
12 weeks
Title
Adverse Event
Description
Number of adverse events
Time Frame
1 -12 weeks
Secondary Outcome Measure Information:
Title
Pain intensity: PROMIS® Pain Intensity-Short Form (SF)3a
Description
PROMIS® Pain Intensity-Short Form (SF)3a (A 5-point (from 1= Had no pain to 5= Very Severe) rating scale is used in each of the 3 items; higher results mean higher intensity of pain.
Time Frame
Change from Baseline pain intensity at 6, 12, and 24-week time points
Title
Pain interference: PROMIS® Pain Interference -8a
Description
PROMIS® Pain Interference -8a (A 5-point (from 1= Not at all to 5= Very much) rating scale is used on each of the 8 items; higher scores reflect greater pain interference
Time Frame
Change from Baseline pain interference at 6, 12, and 24-week time points
Title
Chronic pain acceptance: Chronic Pain Acceptance Questionnaire
Description
Chronic Pain Acceptance Questionnaire (A seven-point (from 0= Never to 6 = Always) rating scale is used in each of the 20 items; higher results mean high pain acceptance)
Time Frame
Change from Baseline chronic pain acceptance at 6, 12, and 24-week time points
Title
Mindfulness
Description
Cognitive and Affective Mindfulness Scale (A 4-point (Rarely/not at all to almost always) rating scale is used in each of the 12 items; higher values reflect higher mindful qualities
Time Frame
Change from Baseline mindfulness at 6, 12, and 24-week time points
Title
Physical activity (Accelerometry data)
Description
An accelerometer, ActiGraph GT9X will be used to measure the change in participants physical activity between baseline and 2 endpoints (12 and 24 weeks)
Time Frame
Change from Baseline physical activity at 12, and 24-week time points
Title
Physical activity (Self-report data)
Description
Self-report assessment of physical activity will be done through UCLA Activity Scale (One item out of 10 will be checked to best describe current activity level)
Time Frame
Change from Baseline physical activity at 6, 12, and 24-week time points
Other Pre-specified Outcome Measures:
Title
Physical Function
Description
PROMIS® Physical function-20a (A 5-point (5= without any difficulty to 1= Unable to do) rating scale is used in each of the 20 items; higher values reflect higher abilities to physically function
Time Frame
Change from Baseline physical function at 6, 12, and 24-week time points
Title
Depression
Description
PROMIS® Emotional Distress-Depression-SF 4a (A 5-point (1= Never to 5= Always) rating scale is used in each of the 4 items; higher values reflect higher levels of depression
Time Frame
Change from Baseline depression at 6, 12, and 24-week time points
Title
Sleep Disturbance
Description
PROMIS® Sleep Disturbance-4a (A 5-point (5= Very poor to 1= Very good) rating scale is used in each of the 4 items; higher values reflect higher levels of sleep disturbances
Time Frame
Change from Baseline sleep disturbance at 6, 12, and 24-week time points
Title
Pain Catastrophizing: Pain Catastrophizing Scale
Description
Pain Catastrophizing Scale - short form(SF)-4a (A 4-point (0= Not at all to 4= All the time) rating scale is used in each of the 4 items; higher scores reflect greater pain catastrophizing
Time Frame
Change from Baseline pain catastrophizing at 6, 12, and 24-week time points
Title
Kinesiophobia
Description
Tampa Scale of Kinesiophobia (A 4-point (1= Strongly disagree to 4= Strongly agree) rating scale is used in each of the 11 items; higher values reflect higher levels of kinesiophobia
Time Frame
Change from Baseline kinesiophobia at 6, 12, and 24-week time points
Title
Patient Perception of Change
Description
Score on single item Patient Global Impression of Change Rating (range: 1 (No change) to 7 (a great deal better))
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria age > 18 years current non-specific cLBP that has persisted at least 3 months, and has resulted in pain on at least half the day in the past 6 months proficient in English average pain severity and interference ratings >3/10 on a 0-10 numeric rating scale if taking pain medication(s), dosage must be stabilized for a minimum of 3 months patients agree not to seek additional therapies for the duration of this study beyond those already included in their current treatment regimen or new treatments prescribed by their physician naïve to DMT. those who have adequate computer literacy (e.g., know how to use a computer to perform basic tasks such as open/send emails, use internet, fill-out online surveys) and access to the virtual delivery format (i.e., internet service and a personal computer device such as laptop, desktop, tablet PC). Exclusion Criteria: pregnancy severe and/or progressive medical, neurological, substance dependence within the last 6 months or severe mental illness (i.e., psychosis, mania) that would prevent active participation cognitive impairment that prohibits informed consent back surgery in the last 6 months low back pain attributable to a recognizable, known specific pathology (e.g. infection, tumor, osteoporosis, fracture, structural deformity, inflammatory disorder, radicular syndrome, or cauda equina syndrome wheelchair-bound or unable to move without assistance involvement in impending litigation or judgment for disability or worker's compensation.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Minjung Shim, PhD
Phone
267-359-5592
Email
ms344@drexel.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Adam Gonzalez, PhD
Phone
631-632-8675
Email
adam.gonzalez@stonybrookmedicine.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Minjung Shim, PhD
Organizational Affiliation
Drexel University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Adam Gonzalez, PhD
Organizational Affiliation
Stony Brook University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Drexel Universitsy
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19102
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Minjung Shim, PhD
Phone
267-359-5592
Email
ms344@drexel.edu
First Name & Middle Initial & Last Name & Degree
Bradt, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Mindfulness-based Dance/Movement Therapy for Chronic Low Back Pain

We'll reach out to this number within 24 hrs